Learning Objectives: 

1. Identify cancer patients at low, intermediate and high risk for VTE using risk assessment tool

2. Evaluate the indications, benefits and risks of pharmacologic thromboprophylaxis options

3. Apply clinical judgement to integrate thromboprophylaxis with patient specific factors